Colinz Laboratories Ltd files its Integrated Financial Filing for Q4 and year ended 31 March 2026 with BSE.
Submission is pursuant to SEBI Circular dated 31 December 2024 and BSE Circular 20250102-4.
All standard annexures for deviation, defaults, and related party transactions are marked as not applicable.
The filing will be made available on the company's official website.